SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022220
Filing Date
2020-08-14
Accepted
2020-08-14 15:35:50
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_inspyrtherap.htm 10-Q 587352
2 CERTIFICATION f10q0620ex31-1_inspyrtherap.htm EX-31.1 9524
3 CERTIFICATION f10q0620ex31-2_inspyrtherap.htm EX-31.2 9613
4 CERTIFICATION f10q0620ex32-1_inspyrtherap.htm EX-32.1 4694
5 CERTIFICATION f10q0620ex32-2_inspyrtherap.htm EX-32.2 4775
  Complete submission text file 0001213900-20-022220.txt   2317742

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20200630.xml EX-101.INS 284569
7 XBRL SCHEMA FILE nspx-20200630.xsd EX-101.SCH 33087
8 XBRL CALCULATION FILE nspx-20200630_cal.xml EX-101.CAL 31600
9 XBRL DEFINITION FILE nspx-20200630_def.xml EX-101.DEF 90808
10 XBRL LABEL FILE nspx-20200630_lab.xml EX-101.LAB 203736
11 XBRL PRESENTATION FILE nspx-20200630_pre.xml EX-101.PRE 147908
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 201104604
SIC: 2834 Pharmaceutical Preparations